nedaplatin has been researched along with Thrombopenia in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Song, C; Sun, Z; Wang, W; Xu, H; Yin, J | 1 |
| Liang, X; Liu, Q; Yang, S; Yao, W | 1 |
| Hou, A; Jiang, Z; Liu, W; Mu, Y; Tan, S; Yu, C | 1 |
| Kogashiwa, Y; Kohno, N; Sato, D; Tsukahara, K; Yamauchi, K | 1 |
| Qiu, ZQ; Zhao, K | 1 |
| Cao, H; Feng, J; Liu, S; Liu, Y; Ma, R; Wu, J; Yu, S | 1 |
| Abiko, K; Abou-Taleb, HA; Baba, T; Hamanishi, J; Horikawa, N; Kitamura, S; Konishi, I; Koshiyama, M; Matsumura, N; Murakami, R; Taha, AA; Yamaguchi, K; Yamanoi, K | 1 |
| Kunitoh, H; Kurata, T; Ohe, Y; Saijo, N; Sekine, I; Tamura, T; Yamamoto, N | 1 |
| Guo, JF; Nie, XY; Peng, J; Wang, B; Wu, F; Xing, H; Zhang, B; Zhu, GY | 1 |
| Hamada, Y; Hayakawa, K; Kotani, A; Kusu, F; Naitoh, H; Niibe, Y; Takayanagi, R; Tsunoda, S; Unno, N; Yago, K; Yamada, Y | 1 |
| Li, T; Yu, CH; Zhu, WG | 1 |
| Ke, QH; Liu, Z; Su, XY; Yang, JY; Zhang, WT; Zhou, SQ | 1 |
| Iwasaki, A; Miyake, M; Nagahata, S; Ogawa, T; Ohbayashi, Y; Ohkawa, M; Toyama, Y | 1 |
| Demura, T; Harabayashi, T; Ishikawa, R; Koyanagi, T; Mitsuhashi, K; Murakumo, M; Seki, H; Shinohara, N; Suzuki, S; Toyota, H | 1 |
| Fukuoka, M; Kaneda, H; Kurata, T; Nakagawa, K; Nogami, T; Satoh, T; Tamura, K; Yamamoto, N | 1 |
| Fukushima, H; Hirasawa, N; Ishigaki, T; Ishihara, S; Itoh, Y; Iwata, M; Kawase, S; Kumada, S; Mori, Y; Nakamura, T; Okuda, T; Ota, T; Satoh, C; Suzuki, K; Takai, K; Yanagawa, S | 1 |
| Kamiura, S; Morishige, K; Ohta, Y; Saji, F; Yamamoto, T | 1 |
| Abe, S; Araki, H; Hareyama, M; Iyama, S; Kato, J; Miyanishi, K; Murase, K; Nagakura, H; Niitsu, Y; Okamoto, T; Sagawa, T; Sato, T; Sato, Y; Takayama, T; Takimoto, R | 1 |
| Kawauchi, A; Mikami, K; Miki, T; Mizutani, Y; Nakamura, T; Nakanishi, H; Nomoto, T | 1 |
| Dai, AD; Guan, ZZ; Hu, XH; Huang, H; Jiang, WQ; Li, XG; Liu, YL; Ma, ZY; Pan, LX; Shi, YX; Wang, JH; Xie, WM; Xu, RH; Zhang, C; Zhuang, W | 1 |
| Ando, T; Maruoka, Y; Ogiuchi, H; Ogiuchi, Y | 1 |
| Chen, LK; Guan, ZZ; Hang, Y; Xu, GC; Yang, QY | 1 |
| Isono, K; Kakegawa, T; Kurihara, M; Nabeya, K; Ota, K; Taguchi, T; Wakui, A | 1 |
| Hayasaki, K; Horiuchi, M; Inuyama, Y; Komiyama, S; Miyake, H; Ota, K | 1 |
| Eguchi, K; Fukuda, M; Kojima, A; Morita, M; Nakagawa, K; Ohe, Y; Sasaki, Y; Shinkai, T; Tamura, T; Yamada, K | 1 |
| Majima, H | 1 |
| Ariyoshi, Y; Ota, K | 1 |
| Akasaka, Y; Machida, T | 1 |
1 review(s) available for nedaplatin and Thrombopenia
| Article | Year |
|---|---|
Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis.
Topics: Antineoplastic Agents; Asia, Eastern; Asian People; Carcinoma, Non-Small-Cell Lung; Cisplatin; Databases, Factual; Humans; Lung Neoplasms; Nausea; Odds Ratio; Organoplatinum Compounds; Regression Analysis; Survival Rate; Thrombocytopenia | 2015 |
13 trial(s) available for nedaplatin and Thrombopenia
| Article | Year |
|---|---|
Shen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum-based anticancer reagents.
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelets; Bone Marrow; Bone Marrow Diseases; Carboplatin; Cisplatin; Drug Therapy, Combination; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Neoplasms; Organoplatinum Compounds; Platelet Activation; Platelet Aggregation; Platinum Compounds; Thrombocytopenia; Young Adult | 2017 |
Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxonic Acid; Tegafur; Thrombocytopenia; Treatment Outcome | 2013 |
Expression of ERCC1, RRM1 and LRP in non-small cell lung cancers and their influence on chemotherapeutic efficacy of gemcitabine concomitant with nedaplatin.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Nausea; Organoplatinum Compounds; Ribonucleoside Diphosphate Reductase; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vault Ribonucleoprotein Particles; Vomiting | 2014 |
A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Kidney Function Tests; Leukopenia; Lung Neoplasms; Male; Maximum Tolerated Dose; Neutropenia; Organoplatinum Compounds; Thrombocytopenia | 2009 |
A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Taxoids; Thrombocytopenia | 2010 |
[Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Diarrhea; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Leukopenia; Megestrol; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Particle Accelerators; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms | 2011 |
Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Thrombocytopenia | 2004 |
[Combination chemotherapy with nedaplatin and paclitaxel for ovarian cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Treatment Outcome | 2004 |
A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Radiotherapy, Adjuvant; Remission Induction; Severity of Illness Index; Survival Rate; Thrombocytopenia; Treatment Outcome | 2006 |
[Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Prospective Studies; Remission Induction; Thrombocytopenia | 2006 |
[Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study].
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Paclitaxel; Prospective Studies; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2007 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Esophageal Neoplasms; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Nausea; Organoplatinum Compounds; Stomach Neoplasms; Thrombocytopenia | 1992 |
[An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Topics: Adenocarcinoma; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Organoplatinum Compounds; Thrombocytopenia | 1992 |
14 other study(ies) available for nedaplatin and Thrombopenia
| Article | Year |
|---|---|
Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma.
Topics: Agranulocytosis; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Male; Neoadjuvant Therapy; Paclitaxel; Thrombocytopenia | 2022 |
Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Retrospective Studies; Thrombocytopenia | 2022 |
Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Gamma Rays; Humans; Hysterectomy; Injections, Intravenous; Irinotecan; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Survival Analysis; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Initial analysis of relationship between plasma platinum concentration and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in combination with radiotherapy for cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Pilot Projects; Platinum; Thrombocytopenia; Uterine Cervical Neoplasms | 2010 |
[Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Radiotherapy, Conformal; Thrombocytopenia; Uterine Cervical Neoplasms; Vomiting | 2011 |
[Clinical study of the area under the blood concentration-time curve of targeting intra-arterial infusion chemotherapy with nedaplatin for primary oral cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Glomerular Filtration Rate; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Thrombocytopenia | 2004 |
[Paclitaxel, ifosfamide, nedaplatin (TIN) for patients with metastatic urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Survival Rate; Thrombocytopenia; Urologic Neoplasms | 2004 |
[Chemoradiation using 5-fluorouracil (5-FU) and nedaplatin (NDP) for gynecological malignancy--the relation between hemotoxicity and sequence of 5-FU and NDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Genital Neoplasms, Female; Hemoglobins; Humans; Middle Aged; Organoplatinum Compounds; Thrombocytopenia | 2004 |
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia | 2006 |
[Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Nausea; Organoplatinum Compounds; Oxonic Acid; Tegafur; Thrombocytopenia; Vomiting, Anticipatory | 2007 |
Prediction from creatinine clearance of thrombocytopenia and recommended dose in patients receiving (glycolato-O,O')-diammine platinum (II) (NSC 375101D).
Topics: Adult; Aged; Antineoplastic Agents; Creatinine; Female; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Organoplatinum Compounds; Platelet Count; Thrombocytopenia | 1990 |
[Present status of cisplatin (CDDP) analogues in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemical Phenomena; Chemistry; Cisplatin; Female; Humans; Kidney; Leukopenia; Nervous System; Organoplatinum Compounds; Platinum; Protein Binding; Thrombocytopenia | 1989 |
[Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; Cisplatin; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Kidney; Leukopenia; Mice; Neoplasms; Neoplasms, Experimental; Organoplatinum Compounds; Thrombocytopenia | 1989 |
[Experimental evaluation of cisplatin analogous in urogenital cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Evaluation; Humans; Kidney; Leukopenia; Male; Mice; Mice, Inbred Strains; Middle Aged; Organoplatinum Compounds; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testicular Neoplasms; Testis; Thrombocytopenia; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1989 |